Anaesthesia, Intensive Care and Pain Medicine - St Vincent's ...
Anaesthesia, Intensive Care and Pain Medicine - St Vincent's ...
Anaesthesia, Intensive Care and Pain Medicine - St Vincent's ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Department of Endocrinology <strong>and</strong> Diabetes Mellitus<br />
<strong>St</strong>.Vincent’s Healthcare Group<br />
106<br />
Insulin Pump Therapy, <strong>St</strong> James Hospital, Dublin,October 21-<br />
22nd 2003<br />
Irish Endocrine Society, Armagh 7-8th November 2003<br />
Office for Health Management Course, Tullamore Court Hotel,<br />
10th November 2003<br />
Diabetes Management:An Integrated Approach. Royal College of<br />
Obstetrics <strong>and</strong> Gynaecology, Regent Park,London,1st<br />
December 2003.<br />
Publications<br />
Kelly SN,McKenna TJ <strong>and</strong> Young LS. Modulation of steroidogenic<br />
enzymes by orphan nuclear transcriptional regulation may control<br />
diverse production of cortisol <strong>and</strong> <strong>and</strong>rogens in the human adrenal.<br />
J Endocrinol.2004;181(2):355-65.<br />
Suliman AM, Smith TP, Gibney J <strong>and</strong> McKenna TJ. Frequent<br />
Misdiagnosis <strong>and</strong> Mismanagement of Hyperprolactinemic Patients<br />
before the Introduction of Macroprolactin Screening:Application of a<br />
New <strong>St</strong>rict Laboratory Definition of Macroprolactinemia. Clin<br />
Chem 2003;49(9) 1504-9.<br />
Suliman AM, Freaney R,Smith TP, McBrinn Y, Murray B, McKenna,<br />
TJ. The Impact of Different Glucocorticoid Replacement schedules<br />
on Bone Turnover <strong>and</strong> Insulin Sensitivity in Patients with Adrenal<br />
Insufficiency. Clin Endocrinol (Oxf) 2003 59(3): 380-87.<br />
Smith D, Keane P, Donovan J,Malone K, McKenna TJ,Lithium<br />
encephalopathy. J R Soc Med 2003;96(12):590-1.<br />
Abstracts<br />
The 22nd Joint Meeting of the British Endocrine Societies,<br />
Glasgow, UK 24-26 March 2003: Tuthill A,Curran S,McKenna<br />
M,O'Shea D <strong>and</strong> McKenna TJ. Glycaemic control,weight change<br />
<strong>and</strong> treatment :Examining the relationship in Type 2 diabetes.<br />
Endocrine Abstracts (2003) 5 P203<br />
Smith TP, Gibney J,Kavanagh L,Dickinson A <strong>and</strong> McKenna TJ. A<br />
more rigorous laboratory definition of macroprolactinaemia with<br />
clinical significance. Endocrine Abstracts (2003) 5 P203<br />
Tuthill A,Kelly R,Ryan Y <strong>and</strong> O'Shea D. Orlistat use outside of<br />
clinical trials:The Irish experience. Endocrine Abstracts (2003) 5<br />
P84<br />
McGowan G, Skehan S, Collins C <strong>and</strong> O'Shea D. Comparison of<br />
simultaneous ultrasonography <strong>and</strong> radio-isotope scanning in<br />
hyperthyroid patients as compared with radio-isotope scanning<br />
alone. Endocrine Abstracts (2003) 5 P272<br />
The 85th Annual Endocrine Society Meeting,Philadelphia,June<br />
19 th -22 nd : Smith TP, Gibney J,Kavanagh L,Dickinson A,McKenna<br />
TJ. A more vigorous laboratory definition of marcroprolactinemia<br />
with clinical significance. Book of abstracts P1-641<br />
Irish Endocrine Society 28th Annual Meeting,Armagh, 7 th <strong>and</strong> 8 th<br />
November 2003:Kavanagh L,Smith TP, Gibney J <strong>and</strong> McKenna<br />
TJ. Macroprolactinaemic patients exhibit increased levels of<br />
peripheral blood CD5-positive B lymphocytes. Ir. J.Med.Sci.<br />
2003;172(Supple 1):15.<br />
Smith TP, Gibney J,Kavanagh L, Fahie-Wilson MN <strong>and</strong> McKenna<br />
TJ. Specificity <strong>and</strong> clinical utility of methods for the detection of<br />
macroprolactin. Ir. J. Med.Sci. 2003:172(Supple 1):15-16.<br />
Adamali HI,Gibney J <strong>and</strong> McKenna TJ. Hypothyroidism is less<br />
frequent following radioactive iodine treatment for toxic nodular<br />
goitre than Graves’disease. Ir. J.Med.Sci.2003; 172(Supple 1):17.<br />
Smith D, Murray B, Gibney J <strong>and</strong> McKenna TJ. Application of new<br />
indices of bone activity for evaluation of the response to treatment<br />
of hyperthyroidism <strong>and</strong> Paget’s disease. Ir. J.Med. Sci.2003;<br />
172(Supple 1):17.<br />
Collins O, Noone I <strong>and</strong> O’Shea D. Neurocardiovascular changes<br />
in patients before <strong>and</strong> after treatment of hypothyroidism. Ir. J.Med.<br />
Sci.2003;172(Supple 1):18.<br />
McGowan G,Skehan S, Collins C, McKenna TJ <strong>and</strong> O’Shea D.<br />
Comparison of simultaneous ultrasonography <strong>and</strong> radioisotope<br />
scanning in hyperthyroid patients as compared with radioisotope<br />
scanning alone. Ir. J.Med.Sci.2003; 172(Supple 1):21.<br />
Smith D, McKenna M,Saaidin JN,Al-Aradi A <strong>and</strong> O’Shea D.<br />
Glargine - clinical <strong>and</strong> patient perspective on a new long-acting<br />
insulin. Ir. J.Med Sci.2003;172(Supple 1):30.<br />
A Tuthill,VTuthill,C Barrett, M McKenna,D O’Shea.TJ McKenna<br />
Diastolic blood pressure, waist circumference <strong>and</strong> cardiovascular<br />
disease in patients with obesity <strong>and</strong> type 2 diabetes. Ir. J. Med.Sci.<br />
2003;172(Supple 1):36.<br />
SN Kelly,T J McKenna, LS Young. Secretogogues induce<br />
transcription factor, steroidogenic factor–1 <strong>and</strong> co-activator, steroid<br />
receptor co-activator-1 in the human adrenal gl<strong>and</strong>. Ir. J.Med.Sci.<br />
2003;172(Supple 1):42-43.<br />
<strong>St</strong>aff<br />
Medical Director<br />
Principal Biochemist<br />
Senior Biochemist<br />
Laboratory Aide<br />
Secretary<br />
Professor TJ McKenna<br />
Barbara Murray<br />
Paula O’Shea<br />
Mairead Moore<br />
Siobhan Kelly<br />
Ms Maria Fitzgibbon,who was Principal Biochemist in the<br />
Department has joined the Department of NeuroSciences in<br />
Trinity College as Associate Director. Barbara Murray was<br />
appointed Principal Biochemist in February 03.<br />
Paula O’Shea joined Metabolism as Senior Biochemist in June<br />
03 from the Biochemistry Department.<br />
Service Developments / Activities<br />
Department of<br />
M e t a b o l i s m<br />
Departmental Review<br />
The Metabolism Laboratory provides a comprehensive<br />
analytical <strong>and</strong> consultation service on metabolic problems for<br />
medical <strong>and</strong> surgical patients of <strong>St</strong>.Vincent’s Healthcare Group,<br />
<strong>and</strong> acts as a referring centre for specialist markers of bone <strong>and</strong><br />
renal disease nationally.<br />
The Metabolism Laboratory is recognised as the provider of<br />
specialist tests of Bone Biomarkers,which are acknowledged<br />
internationally as a useful adjunct to the measurement of Bone<br />
Mineral Density.The request for these parameters has increased<br />
with awareness of their usefulness. Bone Biomarke rs are pri m a ri ly<br />
used to monitor the efficacy of anti-resorptive therapy.We <strong>and</strong><br />
o t h e rs have shown that the short term (3 to 6 months) decrease<br />
of bone turnover is significantly correlated with the long term<br />
(2 years ) increase in Bone Mineral Density of both spine <strong>and</strong><br />
hip.With the advent of new treatments such as recombinant<br />
PTH,which is associated with both cortical <strong>and</strong> cancellous bone<br />
benefits - the monitoring of such treatment by way of<br />
measuring Bone Biomarkers should prove to be clinically useful.<br />
An increase in the service for the measurement of Vitamin D<br />
continues to highlight the prevalence of Hypovitaminosis D in<br />
the Irish as well as in several of the ethnic populations now<br />
residing in Irel<strong>and</strong>.<br />
The diabetic patients attending the Diabetic Clinics in <strong>St</strong><br />
Vincent’s University Hospital,<strong>St</strong> Michael’s Hospital <strong>and</strong> <strong>St</strong><br />
Columcille’s Hospital were provided with the Microalbumin<br />
excretion ratio monitoring service.<br />
Research / Future Plans<br />
The effect on bone remodeling by the administration of<br />
glucocortoid therapy was studied <strong>and</strong> published.<br />
The examination of both biochemical <strong>and</strong> cellular markers of<br />
osteoblastic <strong>and</strong> osteoclastic activity in Breast Cancer patients at<br />
high risk of developing skeletal metastases continued.<br />
The study of the effect of disorders of Thyroid Hormone on<br />
Bone Turnover is progressing.<br />
The database of Bone Remodelling <strong>and</strong> Turnover Indices in<br />
metabolic bone disease as well as endocrine disorders are<br />
being examined with a view to identifying indices which will<br />
simplify clinical interpretation.<br />
The impact of eating disorders on bone turnover is<br />
being studied in collaboration with the<br />
Department of Psychiatry <strong>and</strong> Mental<br />
Health.<br />
The laboratory is advancing<br />
the accreditation<br />
programme to<br />
ensure<br />
107